About Us

CellSight is enabling therapies in living subjects through the use of imaging technologies. We are developing PET imaging tracers to be used as companion diagnostics for immunotherapy to help determine efficacy early to enable regimen modification.

We also offer custom imaging research services to enable therapy developers to incorporate imaging during therapy development cycle. We have formed partnerships with several pharmaceutical companies and academia.

Advisory Board

Sanjiv Sam Gambhir, MD, PhD - Chairman of Scientific Advisory Board

Sanjiv Sam Gambhir, MD, PhD

Chairman of Scientific Advisory Board
Virginia and D.K. Ludwig Professor in Cancer Research
Chairman, Department of Radiology at Stanford University School of Medicine
Professor (By courtesy), Bioengineering and Materials Science and Engineering at Stanford
Director, Molecular Imaging Program at Stanford (MIPS)
Director, Canary Center at Stanford for Cancer Early Detection
World renowned figure in molecular imaging with 25 years of biomedical imaging experience. Research focuses on methods to image gene expression in living subjects and imaging fundamental cellular events with optical and radiolabeled probes.
Education:
  • MD and PhD, University of California Los Angeles

Executive Management

Aruna Gambhir - Chief Executive Officer

Aruna Gambhir

Chief Executive Officer
Previously, Executive Director at Siebel Foundation and Marketing Director at Canary Foundation
Prior to that, 20 years experience in Sales, Marketing, Operations and Engineering in startups and multinational companies
Education:
  • BS Biochemistry, University of California Berkeley
  • MS Computer Science, Santa Clara University
  • MBA, University of California Los Angeles
Sam Quezada - Chief Operating Officer

Sam Quezada

Chief Operating Officer
Most recently IP and Corporate Relationsat the Molecular Imaging Program at Stanford
Nearly 30 years experience in Engineering, Marketing and Operations
Education:
  • BSEE and MBA, Stanford University
Shahriar Yaghoubi, PhD - Chief Technology Officer

Shahriar Yaghoubi, PhD

Chief Technology Officer
Managed several industry sponsored pre-clinical imaging projects
Director of Therapeutic Cell Imaging Trials and lead for FDA IND approval for [18F]FHBG
Over twelve years of experience in Molecular Imaging research at Stanford and UCLA
Education:
  • BS Biomedical Engineering, University of Southern California
  • PhD Molecular Medical Pharmacology, University of California Los Angeles